Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kumiko Shimozawa"'
Autor:
Tsuneo Takebayashi, Satoshi Mizuno, Hirohito Takeuchi, Toshihiko Torigoe, Takashi Kirita, Toshihiko Yamashita, Kumiko Shimozawa, Noriyuki Sato, Satoshi Kawaguchi
Publikováno v:
Spine. 33:2483-2488
Study Design. DNA array analysis of dorsal root ganglion (DRG) using a rat model with nerve root constriction. Objective. To determine the molecular changes in the DRG adjacent to the injured nerve root in a lumbar radiculopathy model. Summary of Bac
Autor:
Shigeharu Kimura, Yuki Nabeta, Satoshi Kawaguchi, Kumiko Shimozawa, Satoshi Nagoya, Takuro Wada, Toshihiko Torigoe, Noriyuki Sato, Toshihiko Yamashita, Emiri Nakazawa, Tomohide Tsukahara, Mitsunori Kaya, Hiroko Asanuma
Publikováno v:
Cancer Science. 97:1374-1380
With the goal of establishing efficacious peptide-based immunotherapy for patients with bone and soft tissue sarcomas, we previously identified the cytotoxic T lymphocyte-defined osteosarcoma antigenic gene Papillomavirus binding factor. The present
Autor:
Hiroshi Kitamura, Kumiko Shimozawa, Yoshihiko Hirohashi, Eiji Sato, Toshihiko Torigoe, Emiri Nakazawa, Hiroko Asanuma, Taiji Tsukamoto, Noriyuki Sato, Ichiya Honma
Publikováno v:
Urology. 67:955-959
Objectives To assess the expression of survivin in transitional cell carcinoma of the bladder and to study whether survivin is a transitional cell carcinoma-specific antigen that could be a target for immunotherapy. Survivin, an inhibitor of apoptosi
Autor:
Tomohide Tsukahara, Toshihiko Torigoe, Kazunori Ida, Hiroaki Hiraga, Yoshihiko Hirohashi, Toshihiko Yamashita, Yuriko Sato, Yuki Nabeta, Kumiko Shimozawa, Takuro Wada, Hideyuki Ikeda, Satoshi Kawaguchi, Hiroko Asanuma, Noriyuki Sato, Satoshi Nagoya
Publikováno v:
Cancer Research. 64:5442-5448
The prognosis for patients with osteosarcoma who do not respond to current chemotherapy protocols still remains poor. Toward the goal of establishing efficacious peptide-based immunotherapy for those patients, we previously developed an autologous pa
Autor:
Takako Aoyama, Kumiko Shimozawa, Yukari Noguchi, Kouichi Jinbow, Hideo Bando, Kiyoshi Horita, Makoto Nishizawa, Nobuaki Takahashi, Takashi Yamagishi
Publikováno v:
Fisheries Science. 69:639-643
Four steroidal ketones were isolated from the holdfast of cultivated Laminaria japonica. The structures were characterized as ergosta-4,24(28)-diene-3-one (1), ergosta-4,24(28)-diene-3,6-dione (2), stigmasta-4,24(28)-diene-3-one (3) and stigmasta-4,2
Autor:
Nobuaki Takahashi, Masako Ishikawa, Shinya Hanashima, Hiroeki Sahara, Kengo Sakaguchi, Yoshiyuki Mizushina, K Jimbow, Noriyuki Sato, Fumio Sugawara, Kumiko Shimozawa, Shunya Takahashi, Keisuke Ohta, Takayuki Yamazaki, Shinsei Gasa, Seiji Ohtani
Publikováno v:
Japanese Journal of Cancer Research : Gann
We recently reported that 3'-sulfonoquinovosyl-1'-monoacylglycerol (designated A-5) extracted from sea urchin intestine was effective in suppressing the growth of solid tumors. Although the major fatty acid component of A-5 was a saturated C(16) acid
Autor:
Yasuhiro Mizushima, Tosei Ohmura, Atsuhito Yagihashi, Koichi Hirata, Koji Yamaguchi, Tadashi Katsuramaki, Yasutoshi Kimura, Hiroko Asanuma, Nobuhiko Toyota, Yoshihiko Hirohashi, Tomohisa Furuhata, Kumiko Shimozawa, Yuji Iwayama, Naohiro Nomura, Tetsuhiro Tsuruma, Fumitake Hata, Noriyuki Sato, Toshihiko Torigoe, Minoru Okazaki
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 6, Iss 1, p 24 (2008)
Journal of Translational Medicine, Vol 6, Iss 1, p 24 (2008)
Background We previously reported that survivin-2B, a splicing variant of survivin, was expressed in various types of tumors and that survivin-2B peptide might serve as a potent immunogenic cancer vaccine. The objective of this study was to examine t
Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
Autor:
Satoshi, Kawaguchi, Takuro, Wada, Kazunori, Ida, Yuriko, Sato, Satoshi, Nagoya, Tomohide, Tsukahara, Sigeharu, Kimura, Hiroeki, Sahara, Hideyuki, Ikeda, Kumiko, Shimozawa, Hiroko, Asanuma, Toshihiko, Torigoe, Hiroaki, Hiraga, Takeshi, Ishii, Shin-Ichiro, Tatezaki, Noriyuki, Sato, Toshihiko, Yamashita
Publikováno v:
Journal of Translational Medicine, Vol 3, Iss 1, p 1 (2005)
Journal of Translational Medicine
Journal of Translational Medicine
Background Synovial sarcoma is a high-grade malignant tumor of soft tissue, characterized by the specific chromosomal translocation t(X;18), and its resultant SYT-SSX fusion gene. Despite intensive multimodality therapy, the majority of metastatic or
Autor:
Toshihiko Torigoe, Kengo Sakaguchi, Shunya Takahashi, Takeyuki Yamazaki, Keisuke Ohta, Hiroeki Sahara, Tatsuya Fujita, Kumiko Shimozawa, Nobuaki Takahashi, Fumio Sugawara, Shinya Hanashima, K Jimbow, Mika Takenouchi, Shinsei Gasa, Noriyuki Sato, Yoshitaka Matsumoto, Yoshiyuki Mizushina
Publikováno v:
Transplantation. 74(2)
BACKGROUND It is important to develop new immunosuppressive agents without clinical drawbacks. In this article, we reveal the possibility of a chemically synthetic sulfonolipid that acts as a novel immunosuppressive drug. METHODS We evaluated the imm
Autor:
Hideyuki Ikeda, Yuki Nabeta, Noriyuki Sato, Kumiko Shimozawa, Toshihiko Torigoe, Satoshi Kawaguchi, Takuro Wada, Toshihiko Yamashita, Tomohide Tsukahara, Sigeharu Kimura, Yasuaki Tamura
Publikováno v:
Journal of Immunotherapy. 27:S33-S34